Demand for stock trading apps increases 10x during WallStreetBets saga

Demand for stock trading apps increases 10x during WallStreetBets saga
  TORONTO – The WallStreetBets saga continues to rattle the financial market as more investors show the intention of putting their money in the affected volatile stocks. Amid the saga, interest in trading stocks apps has surged during the period. Data presented by Trading Platforms indicates that United States Google search interest in the phrase ‘Stock trading apps’ has increased ten-fold between... Read More

No such thing as a downturn if you work in government

No such thing as a downturn if you work in government
  EDMONTON – Last year was a surprisingly good year financially for Alberta bureaucrats, unless you were one of the unlucky rubes who doesn’t work for the government. Even though the private sector was shedding jobs by the thousands, many Alberta bureaucrats received pay raises during lockdowns, courtesy of Mr. and Ms. Taxpayer. If that doesn’t seem fair to you,... Read More

PureK Holdings Corp., a plant-based wellness company, to acquire No B.S. Skincare

PureK Holdings Corp., a plant-based wellness company, to acquire No B.S. Skincare
VANCOUVER – PureK Holdings Corp‎. (TSX Venture: PKAN), along with its majority-owned CBD subsidiary company, PureKana, LLC, reported that it has executed a definitive agreement with DTC Brands, LLC to acquire all of the outstanding membership interests of No B.S. Life, LLC , an industry-leading clean-formula skincare and beauty company. No B.S. Skincare was founded to provide consumers a clean... Read More

Algernon Pharmaceuticals launches stroke treatment clinical research with Psychedelic Drug DMT “The Spirit Molecule”

Algernon Pharmaceuticals launches stroke treatment clinical research with Psychedelic Drug DMT “The Spirit Molecule”
VANCOUVER – Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) a clinical stage pharmaceutical development company reported that it has established a clinical research program for the treatment of stroke focused on AP-188, a known psychedelic compound that is part of the tryptamine family (other drugs in the tryptamine family include psilocybin and psilocin). Algernon plans to be the... Read More